About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Bundled Hyperpolypharmacy Deprescribing | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05616689

Bundled Hyperpolypharmacy Deprescribing

Older patients using many prescription drugs (hyperpolypharmacy) may be at increased risk of adverse drug effects. This randomized controlled trial tested the effectiveness and safety of a quality int...

Lead sponsor: Kaiser Permanente•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Kaiser Permanente

Age

76 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Kaiser Permanente patients
•Age ≥76 years
•≥10 drugs (excluding topicals) where
•* drug filled ≥2 times in the past year and
•* drug last filled \< 180 days ago

Exclusion Criteria

•less than 12 months preceding enrollment at Kaiser Permanente
•no primary care practitioner assigned
•on dialysis
•history of heart, liver, lung, breast, or bone marrow transplant
•in hospice
•under active treatment for cancer during the past 12 months
•has received an intervention through the Pharmacy Targeted Deprescribing Program in the preceding year.

Related studies

Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge

NCT06902779 · Polypharmacy

Telecommunication Technology-based Online Survey

NCT06159699 · Risk Factors, Polypharmacy, and more

Improving Medication Management in World Trade Center Responders

NCT07022990 · Polypharmacy

IPGx PILOT Whole Genome Sequencing Extension Cohort

NCT06766071 · Adverse Drug Reaction (ADR), Polypharmacy Patients

Reduction of Polypharmacy in Elderly People With Multiple Diseases

NCT05526963 · Polypharmacy, Multimorbidity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 15, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment2,471

Start dateOct 2020

Last updatedDec 15, 2023

Condition

Locations shown

Kaiser Permanente Division of Research

Oakland, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 15, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions